- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
65 Cards in this Set
- Front
- Back
|
What pharmacokinetic changes occur in hepatic and renal disease?
|
Clearance decreases. Therefore, maintenance dose decreases. Loading dose will stay the same (not dependent on clearance)
|
|
What is a physiologic antagonist?
|
A substance that produces the opposite physiologic effect of an agonist but does not act at the same receptor (epinephrine can act as a bronchodilator by stimulating beta2 receptors in asthma patients that have muscarinic overactivity).
|
|
What organs are part of the sympathetic nervous system but innervated by cholinergic fibers?
|
Adrenal medulla
Sweat glands |
|
What do alpha 1 receptors do?
|
Increase vascular smooth muscle contraction, INCREASE PUPILLARY DILATOR MUSCLE (MYDRIASIS), INCREASE intestinal and bladder sphincter muscle contraction
|
|
What do alpha 2 receptors do?
|
Decrease sympathetic outflow, decrease insulin release
|
|
What do beta 1 receptors do?
|
Increase heart rate and contractility, increase renin release, increase lipolysis
|
|
What do beta 2 receptors do?
|
Vasodilation, bronchodilation, increase heart rate (because of vasodilation), increase contractility, increase lipolysis, increase insulin release, DECREASE UTERINE TONE
|
|
What do M1 receptors do?
|
CNS, enteric nervous system
|
|
What do M2 receptors do?
|
Decrease heart rate and contractility of ATRIA
|
|
What do M3 receptors do?
|
Increase exocrine gland secretions (sweat, gastric acid), increase gut peristalsis, increase bladder contraction, BRONCHOCONSTRICTION, INCREASE PUPILLARY SPHINCTER MUSCLE CONTRACTION (MIOSIS), CILIARY MUSCLE CONTRACTION (accomodation), Increase release of NO (EDRF)
|
|
What do D1 receptors do?
|
Relaxes renal vascular smooth muscle
|
|
What do D2 receptors do?
|
Modulate neurotransmitter release in the brain
|
|
What do H1 receptors do?
|
Increase nasal and bronchial mucus production, CONTRACTION OF BRONCHIOLES, puritus, pain (allergies)
|
|
What do H2 receptors do?
|
Increase gastric acid secretion
|
|
What do V1 receptors do?
|
Increase vascular smooth muscle contraction
|
|
What do V2 receptors do?
|
Increase H2O permeability and reabsorption in the medullary collecting tubules of the kidney
|
|
How is NE release modulated at the sympathetic nerve endings?
|
Autoreceptor- NE binds presynaptic a2 receptors that block further release
AII- Increases M2- Decreases it |
|
What substances block acetylcholine signaling at presynaptic nerve terminals?
|
Hemicholinium- Blocks choline transport into the nerve terminal (RLS)
Vesamicol- blocks choline acetyltransferase Botulinum toxin- Blocks release of ACh into the synapse |
|
What substances block NE signaling at the presynaptic terminals?
|
Metyrosine- Blocks Tyrosine hydroxylase (converts tyrosine to DOPA)
Reserpine- Blocks dopamine conversion to NE Guanethidine, bretrylium- Blocks NE release into the synapse |
|
Bethanechol
|
Mechanism: Direct muscarinic agonist
Use- Postoperative and neurogenic ileus and urinary retention (contracts bowel and bladder smooth muscle) |
|
Carbachol
|
Mechanism: Direct muscarinic agonist
Use- Glaucoma, pupillary contraction, and relief of intraocular pressure |
|
Pilocarpine
|
Mechanism: Direct muscarinic agonist. Resistant to AChE
Use- Potent stimulator of sweat, tears, and saliva, glaucoma (contracts ciliary muscle of eye- open angle; contracts pupillary sphincter- closed angle) |
|
Methacholine
|
Mechanism: Direct muscarinic agonist
Use- Challenge test for diagnosis of asthma (stimulates receptors when airway is inhaled- bronchoconstricts) |
|
Neostigmine
|
Mechanism- AChE inhibitor
Use- Postoperative and neurogenic ileus and urinary retention, MG, reversal of NMJ blockade. NO CNS PENETRATION |
|
Pyridostigmine
|
Mechanism- AChE inhibitor
Use- MG (long acting); does NOT penetrate CNS |
|
Edrophonium
|
Mechanism- AChE inhibitor
Use- Diagnosis of MG (very short acting- 30 minutes) |
|
Physostigmine
|
Mechanism- AChE inhibitor
Use- Glaucoma (crosses BBB) and ATROPINE OVERDOSE |
|
Echothiophate
|
Mechanism- AChE inhibitor
Use- Glaucoma |
|
What are the symptoms of cholinesterase inhibitor poisoning?
|
DUMBBELSS- Diarrhea, urination, miosis, bronchoconstriction, bradycardia, lacrimation, excitation of skeletal muscle and CNS, salivation, sweating
|
|
Atropine, homatropine, tropicamide
|
Mechanism- Muscarinic antagonist
Use- Eye exams (mydriasis) |
|
Benzotropine
|
Mechanism- Muscarinic antagonist
Use- Parkinson's |
|
Scopalamine
|
Mechanism- Muscarinic antagonist
Use- Motion sickness |
|
Ipratropium
|
Mechanism- Muscarinic antagonist
Use- Asthma, COPD |
|
Oxybutynin, glycopyrrolate
|
Mechanism- Muscarinic antagonist
Use- Reduce urgency in mild cystitis and reduce bladder spasms (urge incontinence) |
|
Methscopalamine, propantheline
|
Mechanism- Muscarinic antagonist
Use- Peptic ulcer treatment (reduce acid secretion), decrease salivation, decrease motility |
|
What are the symptoms of atropine toxicity?
|
Increased body temperature (decreased sweating), dry mouth, dry skin, rapid pulse, constipation, DISORIENTATION (DELIRIUM), cycloplegia
|
|
Hexamethonium
|
Mechanism- Blocks nAchR (ganglionic). Only used in experiments to prevent vagal reflexes to changes in blood pressure (reflex bradycardia caused by NE)
Toxicity- Severe orthostatic hypotension, blurred vision, constipation, sexual dysfunction |
|
Epinephrine
|
Mechanism- a1, a2, b1, b2 (low doses selective for b1)
use- Anaphylactic shock, open angle glaucoma, asthma, hypotension (2nd line) |
|
Norepinephrine
|
Mechanism- a1, a2 > b1 (no b2)
Use- Hypotension (but decreases renal perfusion), septic shock |
|
Isoproterenol
|
Mechanism- b1=b2
Use- AV block (rare) |
|
Dopamine
|
Mechanism- D1=D2 > b > a; ionotropic and chronotropic
Use- Cardiogenic shock (increases renal perfusion via D1), heart failure |
|
Dobutamine
|
Mechanism- B1>B2, ionotropic but not chronotropic. Increases cardiac conduction velocity (can lead to arrhythmia)
Use- Heart failure, cardiac stress testing |
|
Phenylephrine
|
Mechanism- a1 > a2
Use- Pupillary dilation, vasoconstriction, nasal decongestion (stops epistaxis) |
|
Metaproterenol, albuterol
|
Mechanism- B2 selective
Use- Acute asthma |
|
Salmeterol
|
Mechanism- B2
Use- Long term asthma |
|
Terbutaline
|
Mechanism- B2
Use- Reduce premature uterine contractions (tocolytic) |
|
Ritodrine
|
Mechanism- B2
Use- Reduce premature uterine contractions |
|
Amphetamine
|
Mechanism- Releases stored catecholamines
Use- Narcolepsy, obesity, ADD, MDD |
|
Ephedrine
|
Mechanism- Releases stored catecholamines
Use- Nasal decongestion, urinary incontinence, hypotension |
|
Cocaine
|
Mechanism- Prevents reuptake of catecholamines
Use- Vasoconstriction and local anesthesia |
|
Clonidine, alpha-methyldopa
|
Mechanism- a2 agonists, decrease central adrenergic outflow
Use- Hypertension, especially if patient has renal disease because no decrease of blood flow to kidney (a-methyldopa safe in pregnancy; clonidine will give rebound hypertension if a dose is missed). Note- causes hemolytic anemia (Coombs positive) |
|
Phenoxybenzamine
|
Mechanism- Blocks a1 and a2 irreversibly
Use- Pheochromocytoma before removing tumor Toxicity- Orthostatic hypotension, reflex tachycardia |
|
Phentolamine
|
Mechanism- Blocks a1 and a2 reversibly
Use- Pheochromocytoma Toxicity- Orthostatic hypotension, reflex tachycardia |
|
Prazosin, terazosin, doxazosin
|
Mechanism- Selective a1 blocker
Use- Hypertension, urinary retention in BPH Toxicity- 1st dose orthostatic hypotension (give at bed time), dizziness, headache |
|
Mirtazapine
|
Mechanism- a2 selective blocker
Use- Depression Toxicity- Sedation, increased serum cholesterol, increased appetite |
|
Beta-blocker uses in general
|
Hypertension: Decrease cardiac output, decrease renin secretion (via b1 on JGA cells)
Angina: Decrease heart rate and contractility (decrease oxygen demand) MI: Decrease mortality SVT: Decrease AV conduction velocity CHF: Slows progression to chronic failure Glaucoma: Decreases secretion of aqueous humor |
|
Beta-blocker toxicity
|
Impotence, exacerbation of asthma, cardiovascular (bradycardia, AV block, CHF), CNS adverse effects (sedation, sleep alterations), mask the signs of hypoglycemia in diabetics because they stop sweating and tachycardia
|
|
Which beta blockers are non-selective (b1 = b2)?
|
Propanolol, timolol, nadolol, and pindolol (N-Z)
|
|
Which beta blockers are b1 selective?
|
Acebutolol (partial agonist), betaxolol, esmolol (short acting), atenolol, metoprolol (A-M)
|
|
Which beta blockers are partial agonists?
|
Pindolol, aceputolol
|
|
Which beta blockers are typically used for MI?
|
Metoprolol, carvedilol
|
|
Which beta blockers are used for SVT?
|
Propanolol, esmolol
|
|
Which beta blocker is used for glaucoma?
|
Timolol
|
|
Which beta blocker is used for essential tremor?
|
Propanolol
|
|
Why is it dangerous to give beta blockers to patients with a cocaine overdose?
|
Because all the adrenergic receptors are activated, including b2 which is actually good because it is causing vasodilation to temper the increase in blood pressure caused by cocaine. If you block beta receptors then only the alpha effects will be seen which is bad
|